![Novel Intranasal Delivery of Sumatriptan as a Route to Rapid and Sustained Relief in the Acute Treatment of Migraine | [current-page:pager]touchNEUROLOGY Novel Intranasal Delivery of Sumatriptan as a Route to Rapid and Sustained Relief in the Acute Treatment of Migraine | [current-page:pager]touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2016/06/Figure_2_AVP-825.png)
Novel Intranasal Delivery of Sumatriptan as a Route to Rapid and Sustained Relief in the Acute Treatment of Migraine | [current-page:pager]touchNEUROLOGY
![Onzetra Xsail (Sumatriptan Nasal Powder Nasal Administration): Uses, Dosage, Side Effects, Interactions, Warning Onzetra Xsail (Sumatriptan Nasal Powder Nasal Administration): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/onzetra-xsail3.gif)
Onzetra Xsail (Sumatriptan Nasal Powder Nasal Administration): Uses, Dosage, Side Effects, Interactions, Warning
![These highlights do not include all the information needed to use Sumatriptan Nasal Spray safely and effectively. See full prescribing information for Sumatriptan Nasal Spray. Sumatriptan nasal sprayInitial U.S. Approval: 1992 These highlights do not include all the information needed to use Sumatriptan Nasal Spray safely and effectively. See full prescribing information for Sumatriptan Nasal Spray. Sumatriptan nasal sprayInitial U.S. Approval: 1992](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=sumatriptannasalspray-spl-graphic-10.jpg&id=579196)
These highlights do not include all the information needed to use Sumatriptan Nasal Spray safely and effectively. See full prescribing information for Sumatriptan Nasal Spray. Sumatriptan nasal sprayInitial U.S. Approval: 1992
![Upsher-Smith Partners With Cove To Expand Access To Its Migraine Medication Tosymra® (Sumatriptan Nasal Spray) 10 mg Upsher-Smith Partners With Cove To Expand Access To Its Migraine Medication Tosymra® (Sumatriptan Nasal Spray) 10 mg](https://mma.prnewswire.com/media/1624194/Tosymra_image.jpg?p=facebook)